Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.
Item(s) added to cart.
For laboratory use only. This product is intended for animal research only and not for use in humans.
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
BombesinRSense™ 680 targeted near infrared (NIR) fluorescent imaging agent is specific for bombesin receptors (BBRs) expressed in many types of cancer. Bombesin-like peptides and their G-protein coupled receptors have been shown to play a role in cancer and are overexpressed in a variety of tumors, including prostate, breast, lung, CNS, gastric, colon, and renal cell carcinomas.
BombesinRSense 680 comprises a 7-amino acid bombesin peptide analog, an NIR fluorophore (ex/em 665/691 nm) and a pharmacokinetic modifier to improve its plasma availability (plasma t1/2 = 30-45 min). This agent can be used to target and quantify upregulation of bombesin receptors (BBR) in vivo associated with tumor proliferation.
|Fluorescent Agent Type||Targeted|
|Optical Imaging Classification||Fluorescence Imaging|
|Product Brand Name||BombesinRSense|
|Quantity in a Package Amount||1.0 Units|
|Unit Size||1 Vial (10 doses)|
|Wave Length||680 nm|
BombesinRSense™680 is a fluorescently-labeled peptide designed to bind to bombesin receptors involved in cancer cell stimulation of proliferation.
BombesinRSense 680 in vivo fluorescent imaging agent protocol